Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
US12421243B2 · kind B2 · utility
0Cited by
7References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 8, 2023 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Sep 8, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.